Cargando…

Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study

STUDY DESIGN. Prospective cohort study. OBJECTIVE. To assess the differences in the clinical and radiological outcomes between oblique lateral interbody fusion (OLIF) and minimally invasive transforaminal lumbar interbody fusion (MI-TLIF). SUMMARY OF BACKGROUND DATA. Nowadays, there is still a contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hai-Feng, Fang, Xiang-Qian, Zhao, Feng-Dong, Zhang, Jian-Feng, Zhao, Xing, Hu, Zhi-Jun, Fan, Shun-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865215/
https://www.ncbi.nlm.nih.gov/pubmed/34855704
http://dx.doi.org/10.1097/BRS.0000000000004303
_version_ 1784655607037427712
author Zhu, Hai-Feng
Fang, Xiang-Qian
Zhao, Feng-Dong
Zhang, Jian-Feng
Zhao, Xing
Hu, Zhi-Jun
Fan, Shun-Wu
author_facet Zhu, Hai-Feng
Fang, Xiang-Qian
Zhao, Feng-Dong
Zhang, Jian-Feng
Zhao, Xing
Hu, Zhi-Jun
Fan, Shun-Wu
author_sort Zhu, Hai-Feng
collection PubMed
description STUDY DESIGN. Prospective cohort study. OBJECTIVE. To assess the differences in the clinical and radiological outcomes between oblique lateral interbody fusion (OLIF) and minimally invasive transforaminal lumbar interbody fusion (MI-TLIF). SUMMARY OF BACKGROUND DATA. Nowadays, there is still a controversy regarding whether OLIF is superior to MI-TLIF in the management of degenerative lumbar disease. METHODS. Between August 3, 2019 and February 3, 2020, 137 patients were assigned to OLIF or MI-TLIF at their request and the surgeon's discretion: 71 in the OLIF group and 66 in the MI-TLIF group. The perioperative data, patient-reported outcomes, radiographic outcomes, and complications were compared between the two groups. RESULTS. The OLIF group showed shorter operation time (110.5 vs.183.8 minutes, P < 0.001), lesser estimated blood loss (123.1 vs. 232.0 mL, P < 0.001), shorter length of hospital stay (5.5 vs. 6.7 days, P < 0.001), and lower serum creatine kinase (CK) (1 day postoperatively) (376.0 vs. 541.8 IU/L, P < 0.01) than that of MI-TLIF group. Both groups showed no significant differences in the visual analog scale (VAS) scores of lower back and leg pain and the Oswestry Disability Index (ODI) scores preoperatively and at 1, 3, and 12 months postoperatively, respectively (P > 0.05). Compared with the MI-TLIF group, the OLIF group showed better restoration of disc height (DH) (4.7/4.6/4.7 vs. 3.7/3.7/3.7 mm, P < 0.01) and lumbar lordosis angle (LLA) (10.5°/10.8°/11.1° vs. 5.8°/5.7°/5.3°, P < 0.001), but not the value of segmental lordosis angle (SLA) (P > 0.05) at 1 day, 1 month, and 1 year postoperatively, respectively. The complication rate of OLIF was higher than that of MI-TLIF (29.4% vs. 9.7%, P < 0.01). CONCLUSION. Compared with MI-TLIF, OLIF showed similar results in terms of patient-reported outcomes, restoration of SLA and fusion rate, and superior results with respect to restoration of DH and LLA, operation time, estimated blood loss, length of hospital stay, and serum CK levels (1 day postoperatively). Even though the complication rate of OLIF is higher than that of MI-TLIF, it does not bring persistent and substantial damage to the patients. Level of Evidence: 3
format Online
Article
Text
id pubmed-8865215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88652152022-02-24 Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study Zhu, Hai-Feng Fang, Xiang-Qian Zhao, Feng-Dong Zhang, Jian-Feng Zhao, Xing Hu, Zhi-Jun Fan, Shun-Wu Spine (Phila Pa 1976) Clinical Case Series STUDY DESIGN. Prospective cohort study. OBJECTIVE. To assess the differences in the clinical and radiological outcomes between oblique lateral interbody fusion (OLIF) and minimally invasive transforaminal lumbar interbody fusion (MI-TLIF). SUMMARY OF BACKGROUND DATA. Nowadays, there is still a controversy regarding whether OLIF is superior to MI-TLIF in the management of degenerative lumbar disease. METHODS. Between August 3, 2019 and February 3, 2020, 137 patients were assigned to OLIF or MI-TLIF at their request and the surgeon's discretion: 71 in the OLIF group and 66 in the MI-TLIF group. The perioperative data, patient-reported outcomes, radiographic outcomes, and complications were compared between the two groups. RESULTS. The OLIF group showed shorter operation time (110.5 vs.183.8 minutes, P < 0.001), lesser estimated blood loss (123.1 vs. 232.0 mL, P < 0.001), shorter length of hospital stay (5.5 vs. 6.7 days, P < 0.001), and lower serum creatine kinase (CK) (1 day postoperatively) (376.0 vs. 541.8 IU/L, P < 0.01) than that of MI-TLIF group. Both groups showed no significant differences in the visual analog scale (VAS) scores of lower back and leg pain and the Oswestry Disability Index (ODI) scores preoperatively and at 1, 3, and 12 months postoperatively, respectively (P > 0.05). Compared with the MI-TLIF group, the OLIF group showed better restoration of disc height (DH) (4.7/4.6/4.7 vs. 3.7/3.7/3.7 mm, P < 0.01) and lumbar lordosis angle (LLA) (10.5°/10.8°/11.1° vs. 5.8°/5.7°/5.3°, P < 0.001), but not the value of segmental lordosis angle (SLA) (P > 0.05) at 1 day, 1 month, and 1 year postoperatively, respectively. The complication rate of OLIF was higher than that of MI-TLIF (29.4% vs. 9.7%, P < 0.01). CONCLUSION. Compared with MI-TLIF, OLIF showed similar results in terms of patient-reported outcomes, restoration of SLA and fusion rate, and superior results with respect to restoration of DH and LLA, operation time, estimated blood loss, length of hospital stay, and serum CK levels (1 day postoperatively). Even though the complication rate of OLIF is higher than that of MI-TLIF, it does not bring persistent and substantial damage to the patients. Level of Evidence: 3 Lippincott Williams & Wilkins 2022-03-15 2021-12-01 /pmc/articles/PMC8865215/ /pubmed/34855704 http://dx.doi.org/10.1097/BRS.0000000000004303 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Clinical Case Series
Zhu, Hai-Feng
Fang, Xiang-Qian
Zhao, Feng-Dong
Zhang, Jian-Feng
Zhao, Xing
Hu, Zhi-Jun
Fan, Shun-Wu
Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study
title Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study
title_full Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study
title_fullStr Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study
title_full_unstemmed Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study
title_short Comparison of Oblique Lateral Interbody Fusion (OLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) for Treatment of Lumbar Degeneration Disease: A Prospective Cohort Study
title_sort comparison of oblique lateral interbody fusion (olif) and minimally invasive transforaminal lumbar interbody fusion (mi-tlif) for treatment of lumbar degeneration disease: a prospective cohort study
topic Clinical Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865215/
https://www.ncbi.nlm.nih.gov/pubmed/34855704
http://dx.doi.org/10.1097/BRS.0000000000004303
work_keys_str_mv AT zhuhaifeng comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy
AT fangxiangqian comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy
AT zhaofengdong comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy
AT zhangjianfeng comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy
AT zhaoxing comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy
AT huzhijun comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy
AT fanshunwu comparisonofobliquelateralinterbodyfusionolifandminimallyinvasivetransforaminallumbarinterbodyfusionmitliffortreatmentoflumbardegenerationdiseaseaprospectivecohortstudy